Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04900623 |
|
Recruitment Status :
Recruiting
First Posted : May 25, 2021
Last Update Posted : July 11, 2023
|
Sponsor:
Jonathan Schoenfeld, MD, MPH
Collaborator:
Naveris
Information provided by (Responsible Party):
Jonathan Schoenfeld, MD, MPH, Brigham and Women's Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 1, 2030 |
| Estimated Study Completion Date : | June 1, 2032 |